Dare Bioscience
NASDAQ: DARESan Diego, US · Delaware corporation · 1 known investors
Biotech
Founders & leadership
MH
MarDee Haring-LaytonChief Accounting Officer
SM
Sabrina Martucci JohnsonPresident and Chief Executive Officer
CD
Christopher D.T. GuiffreExecutive Officer, Director
GB
Gregg BeloffExecutive Officer
AV
Alejandra V. CarvajalExecutive Officer
AS
Adrian SenderowiczExecutive Officer
DR
David R. ParkinsonDirector
WT
William T. McKeeDirector
AL
Alan L. CraneDirector
DW
David WaltDirector
SA
Stuart A. ArbuckleDirector
PA
Paul A. FriedmanDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$15MofferedNov 2024 · 1 investors · BiotechnologyRule 506(b)
▶$15MofferedNov 2024 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- MarDee Haring-LaytonExecutive Officer
- Jessica GrossmanDirector
- William H. RastetterDirector
- Robin SteeleDirector
- Susan L. KelleyDirector
- Sabrina Martucci JohnsonExecutive Officer, Director
- Gregory W. MatzDirector
- Offering amount
- $15M
- First sale
- Oct 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.7MraisedDec 2023 · 1 investors · BiotechnologyRule 506(b)
▶$1.7MraisedDec 2023 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Sophia N. Ononye-OnyiaDirector
- Jessica D. GrossmanDirector
- Cheryl R. BlanchardDirector
- Susan L. KelleyDirector
- Robin J. SteeleDirector
- Lisa Walters-HoffertExecutive Officer
- William H. RastetterDirector
- Sabrina Martucci JohnsonExecutive Officer, Director
- Gregory W. MatzDirector
- Offering amount
- $4.2M
- Amount sold
- $1.7M
- First sale
- Dec 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.5MraisedSep 2021 · 28 investors · BiotechnologyRule 506(b)
▶$3.5MraisedSep 2021 · 28 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robin J. SteeleDirector
- Susan L. KelleyDirector
- Lisa Walters-HoffertExecutive Officer
- Jessica D. GrossmanDirector
- Cheryl BlanchardDirector
- William H. RastetterDirector
- Gregory W. MatzDirector
- Sabrina Martucci JohnsonExecutive Officer, Director
- Offering amount
- $3.5M
- Amount sold
- $3.5M
- First sale
- Nov 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$20.7MraisedJul 2017 · 18 investors · BiotechnologyRule 506(b)
▶$20.7MraisedJul 2017 · 18 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robin J. SteeleDirector
- Lisa Walters-HoffertExecutive Officer
- Roger L. HawleyDirector
- William H. RastetterDirector
- Susan L. KelleyDirector
- Sabrina Martucci JohnsonExecutive Officer, Director
- Offering amount
- $20.7M
- Amount sold
- $20.7M
- First sale
- Jul 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1raisedOct 2016 · 1 investors · PharmaceuticalsRule 506(b)
▶$1raisedOct 2016 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Christopher D.T. GuiffreExecutive Officer, Director
- Gregg BeloffExecutive Officer
- Alejandra V. CarvajalExecutive Officer
- Adrian SenderowiczExecutive Officer
- David R. ParkinsonDirector
- William H. RastetterDirector
- William T. McKeeDirector
- Alan L. CraneDirector
- Susan L. KelleyDirector
- David WaltDirector
- Stuart A. ArbuckleDirector
- Paul A. FriedmanDirector
- Offering amount
- $1
- Amount sold
- $1
- First sale
- Oct 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.